3 years ago

Manejo del linfedema secundario a cáncer de mama empleando terapia descongestiva compleja con presoterapia multicompartimental secuencial. Experiencias en una unidad de linfedema

M. Rodríguez Manso, R. Martín Mourelle, S. Otero Villaverde, E. Canosa Hermida

Publication date: Available online 18 May 2018

Source: Rehabilitación

Author(s): M. Rodríguez Manso, R. Martín Mourelle, S. Otero Villaverde, E. Canosa Hermida


El protocolo de tratamiento para los pacientes con linfedema sigue siendo controvertido. El objetivo de este trabajo es analizar el resultado de la Terapia Descongestiva Compleja con presoterapia multicompartimental secuencial aplicada por primera vez a pacientes con linfedema secundario a cáncer de mama en una Unidad de Linfedema.

Material y métodos

Este estudio observacional con seguimiento retrospectivo está basado en la revisión de historias clínicas durante el periodo 2013-2016. 48 pacientes reunieron los criterios de inclusión de: diagnóstico de linfedema secundario a cáncer de mama, realizar por primera vez sesiones completas de Terapia Descongestiva Compleja (con drenaje linfático manual, presoterapia multicompartimental secuencial y vendaje multicapas) haber realizado la toma de medidas y firmar el consentimiento informado. La valoración se realizó comparando las medidas en centímetros del perímetro del miembro tratado y el contralateral en 7 niveles en 3 momentos (inicial, postratamiento y en la revisión) usando la fórmula de Kuhnke para obtener los volúmenes aproximados.


La diferencia entre los volúmenes de ambos miembros bajó desde el 21,61% de media inicial, al 15,98% a corto plazo y al 15,64% a medio plazo, consiguiéndose bajada de volumen en 39 de los pacientes y bajada del grado de linfedema en 21 de ellos.


Los resultados avalan la elección de la Terapia Descongestiva Compleja con presoterapia multicompartimental secuencial como tratamiento estándar en el linfedema secundario a cáncer de mama. Es necesaria más investigación con estudios objetivables y reproducibles que incluyan resultados a largo plazo.


The optimal treatment protocol for lymphoedema patients is still controversial. Therefore, the aim of this study was to analyse the results of Complex Decongestive Therapy with intermittent multi-chamber pneumatic compression applied for the first time in patients with breast cancer-related lymphoedema in a Lymphoedema Unit.

Material and methods

This retrospective observational study was based on a review of medical records from 2013-2016. A total of 48 patients met the inclusion criteria, ie, those who had received a diagnosis of breast cancer-related lymphoedema, had undergone complete sessions of Complex Decongestive Therapy (with manual lymphatic drainage, intermittent multi-chamber pneumatic compression and multi-layer bandaging) for the first time, had available recorded measurements and had signed an informed consent form. The assessment was conducted by comparing the measurement in centimetres of the circumference of the affected limb with the contralateral measurements at 7 levels in 3 time intervals (initial, post-treatment and at the medical follow-up). The Kuhnke method was used to obtain the approximate volumes.


The difference between the volumes of the two limbs decreased from an initial mean of 21.61%, to 15.98% in the short-term and 15.64% in the medium-term, so there was a volume reduction in 39 patients. Moreover, the stage of lymphoedema decreased in 21 of them.


The results support the choice of Complex Decongestive Therapy with intermittent multi-chamber pneumatic compression as a standard treatment in breast cancer-related lymphoedema. Further research is required on this issue with measurable and reproducible studies that include long-term-results.

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.